Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-20Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G [Phase 2]
Phase 2 trial of ADX-097 for IgA nephropathy, lupus nephritis, and C3 glomerulopathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept [Phase 2]
A phase 2 rollover trial update assessing long-term safety and efficacy of atacicept in IgA nephropathy, currently enrolling by invitation.
-
CLINICAL_TRIALS other · 2025-04-06Clinical Trial Update: Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue [Phase 2]
Phase 2 clinical trial evaluating Sibeprenlimab for immunoglobulin A nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Clinical trial RENAL AID from The Rogosin Institute is investigating novel analytes linked to autoimmune, inflammatory, and diabetic nephrop…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Rituximab and RASi in Patients with IgAN [Phase 4]
Phase 4 clinical trial evaluating rituximab plus renin-angiotensin system inhibitors in patients with IgA nephropathy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Correlation of Microbiome and Metabonomics With IgA Nephropathy
A clinical trial evaluating the relationship between the gut microbiome, metabonomics, and IgA nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy [NA]
The document reports a completed clinical trial assessing fecal microbiota transplantation for IgA nephropathy, sponsored by Shanxi Provinci…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of SHR-2010 Injection in primary IgA nephropathy has been terminated.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria [Phase 3]
A Phase 3 clinical trial evaluating SC0062 capsule for IgA nephropathy with proteinuria is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies [Phase 2]
Phase II trial of APL-2 in glomerulopathies completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TESTING -ON Post-Trial ObservatioNal Cohort Study
A post-trial observational cohort study named TESTING-ON, sponsored by The George Institute, is currently recruiting to observe outcomes in …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Felzartamab (MOR202) in immunoglobulin A nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy [Phase 2]
This update notes the completion of a Phase 2 study evaluating IONIS-FB-LRx for primary IgA nephropathy, assessing its effectiveness and saf…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases [Phase 2]
A Phase 2 clinical trial of SGB-9768 for complement-mediated kidney diseases, including IgA nephropathy and C3 glomerulopathy, has not yet s…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases [Phase 1, Phase 2]
SCTC21C is being studied for plasma cell–driven autoimmune diseases, including IgA nephropathy, in Phase 1/2 trials that are not yet recruit…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Study of Probiotics in IgA Nephropathy [NA]
A clinical trial is evaluating a probiotic preparation in IgA nephropathy. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease [Phase 2]
This clinical trial update indicates that SC0062 is being investigated in a Phase 2 study for chronic kidney disease, including diabetic kid…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Raman Spectroscopy Diagnosis of Kidney Diseases
This update describes an ongoing clinical trial evaluating Raman spectroscopy as a diagnostic tool for kidney diseases, including IgA nephro…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy [Phase 2]
Phase 2 study evaluating the safety and activity of Sparsentan in incident patients with immunoglobulin A nephropathy; the trial is currentl…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) [Phase 3]
A Phase 3 extension update reporting efficacy and safety outcomes for patients with primary IgA nephropathy who completed the NEF-301 study …
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Efficacy and Safety of Telitacicept in IgAN [NA]
Clinical trial update on the efficacy and safety of Telitacicept for IgA nephropathy; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy [Phase 3]
Phase 3 trial update for Nefecon in adults with primary IgA nephropathy reports efficacy and safety outcomes; results have been posted follo…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients [EARLY_Phase 1]
Early-phase (Phase 1) trial update for IM19 CAR-T cell therapy in IgA nephropathy and membranous nephropathy; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy [NA]
A clinical trial investigating the role of follicular helper T cells and the regulatory follicular helper T cell to T cell ratio in IgA neph…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN) [Phase 2]
Phase 2 clinical trial to evaluate the efficacy and safety of MY008211A in subjects with immunoglobulin A nephropathy (IgAN). The study is c…